Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Neurosci Biobehav Rev. 2017 Feb 3;76(Pt A):99–110. doi: 10.1016/j.neubiorev.2016.12.037

Table 1.

Pharmacological manipulations affecting social and repetitive behavior in the BTBR T+Itpr3tf/J mouse.

Manipulation Mechanism Social interaction Self-grooming Marble burying Other tests Reference
Excitatory/Inhibitory imbalance 2-Methyl-6-(phenylethynyl) pyridine
(MPEP)
selective mGluR5 antagonist = graphic file with name nihms852290ig1.jpg Silverman et al. 2010a
graphic file with name nihms852290ig1.jpg Burket et al 2011
Object location memory Inline graphic Seese et al. 2014
MWM Inline graphic
Rotarod Inline graphic
Yang et al. 2015
GRN-529 selective negative allosteric modulator of the mGluR5 receptor Inline graphic soc sniffing
Inline graphic soc appr
graphic file with name nihms852290ig1.jpg Silverman et al. 2012
D-cycloserine partial glycineB site agonist targeting NMDAR graphic file with name nihms852290ig3.jpg graphic file with name nihms852290ig1.jpg Rearing Inline graphic Burket et al. 2013
CX1837, CX1739 and CX546 AMPAKINEs Inline graphic soc sniffing = OF = (except for CX546, which caused sedation)
CX1837 Inline graphic novel object recognition
Silverman et al. 2013
CX929 AMPAKINE Object location memory = Seese et al. 2014
Diazepam positive allosteric modulator of GABAA receptors Inline graphic soc appr Pobbe et al. 2011
Inline graphic under Defensor et al 2011
EPM arm entries Inline graphic Kazdoba et al. 2016
Diazepam at P15–28 Multi-sensory integration Inline graphic Gogolla et al. 2014
Clonazepam Inline graphic soc appr Circling Inline graphic
OF, EPM activity =
Fear memory Inline graphic
Han et al. 2014
Allopregnanolone EPM arm entries Inline graphic Kazdoba et al. 2016
Ganaxolone Inline graphic soc sniffing
Inline graphic soc appr
= = OF, EPM activity Inline graphic
L-838,417 α2,3 subunit-selective positive allosteric modulator of GABAA receptors Inline graphic soc appr Fear memory (short and long term) Inline graphic Han et al. 2014
Zolpidem α1 subunit-selective positive GABAA modulator Inline graphic soc appr at a high dose Fear memory (only short term) Inline graphic
R-baclofen selective GABAB receptor agonist Inline graphic soc appr graphic file with name nihms852290ig1.jpg graphic file with name nihms852290ig1.jpg Silverman et al. 2015
monoaminergic Risperidone Qualitatively atypical antipsychotic
(5HT1A,B,D,5A,6,7 antagonist, 5HT2A,B,C inverse agonist, D1,2,4,5 antagonist, D3 inverse agonist, α1A,B, 2A,B antagonist, H1,2 inverse agonist)
= graphic file with name nihms852290ig1.jpg Gould et al. 2011
= EPM = Chadman 2011
Probabilistic learning Inline graphic Amodeo et al. 2014
Fluoxetine SERT blocker Inline graphic soc appr = Gould et al. 2011
Inline graphic soc appr EPM = Chadman 2011
Buspirone 5HT1A receptor partial-agonist Inline graphic soc appr = Gould et al. 2011
M100907 5HT2A antagonist Probabilistic learning Inline graphic Amodeo et al. 2014
graphic file with name nihms852290ig1.jpg Amodeo et al. 2016a and b
Citalopram selective serotonin reuptake inhibitor (SSRI) Tail suspension Inline graphic Crowley et al. 2005
Dietary tryptophan 5HT precursor Inline graphic soc appr but not soc novelty = = Zhang et al. 2015
D-amphetamine Psychostimulant, acting via DA-ergic enhancement in the mesolimbic circuit Inline graphic
Inline graphic duration of soc sniffing
graphic file with name nihms852290ig1.jpg Silverman et al. 2013
3,4-Methylenedioxym ethamphetamine (MDMA, ecstasy) Psychostimulant, presynaptic releasing agent of serotonin, norepinephrine, and dopamine Locomotor activity = Onaivi et al. 2011
metamphetamine Psychostimulant, full agonist of trace amine-associated receptor 1 (TAAR1)
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Neurotoxin destroying dopaminergic neurons
(−)-trans9-tetrahydrocannabi nol partial agonist activity at the cannabinoid receptor CB1 Spontaneous wheel running Inline graphic
Acetaminophen (paracetamol) cannabinoid CB(1) receptor-mediated inhibition of serotonin (5-HT) transmission in the frontal cortex, 5HT agonism Inline graphic soc appr = Gould et al. 2012
Atomoxetine noradrenergic reuptake inhibitor Fear memory Inline graphic Stapley et al. 2013
cholinergic Oxotremorine Muscarinic acetylcholine receptor (mAChR) agonist graphic file with name nihms852290ig1.jpg graphic file with name nihms852290ig1.jpg Amodeo et al. 2014
Nicotine nicotinic acetylcholine receptor (nAChR) agonist Inline graphic soc appr at low doses Inline graphic at high doses OF activity Inline graphic Wang L et al. 2015
Donepezil (AchEI) Acetylocholinester ase inhibitor Inline graphic soc appr and novelty
Inline graphic soc sniffing
Rigidity in T-maze and jammed running wheel Inline graphic Karvat and Kimchi 2014
other pathways Chronic intranasal oxytocin Neuropeptide, OXTR agonist =
Inline graphic soc sniffing in females
= Juvenile social interaction =
Fear memory =
Bales et al. 2014
Rapamycin mTORC1 inhibitor Inline graphic soc appr
Inline graphic soc sniffing
= Burket et al. 2014
histidine, lysine, threonine diet mTORc1 inhibition = graphic file with name nihms852290ig1.jpg Wu et al. 2016
Sodium butyrate HDAC inhibitor Inline graphic soc novelty at low doses = graphic file with name nihms852290ig1.jpg Kratsman et al. 2016
SR1078 retinoic acid receptor-related orphan receptor α (RORα) agonist graphic file with name nihms852290ig1.jpg graphic file with name nihms852290ig1.jpg Wang et al 2016
GW7647 Peroxisome proliferator-activated receptor agonist graphic file with name nihms852290ig1.jpg graphic file with name nihms852290ig1.jpg D’Agostino et al. 2015
sgp130Fc IL-6 trans-signaling blocker Inline graphic soc appr Inline graphic= Wei et al. 2016c

soc appr – social approach in the three chambered apparatus

soc novelty – preference for novel mouse in the third phase of three chambered apparatus social approach test

soc sniffing – either during social approach test in the three chambered apparatus or in close dyadic interaction

MWM – Morris Water Maze

OF – Open Field test

EPM – Elevated Plus Maze

HHS Vulnerability Disclosure